← Open Payments lookup

EMMA CROCAMO: Open Payments

NPI 1881309979 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$901 in 30 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $867 · 2025 $901

Food & beverage: $888Education: $12
CompanyPaymentsAmount
Madrigal Pharmaceuticals3$242
ABBVIE INC.7$222
Takeda Pharmaceuticals U.S.A., Inc.3$74
PFIZER INC.3$67
Gilead Sciences, Inc.3$58
Regeneron Healthcare Solutions, Inc.1$35
QOL Medical, LLC1$32
Lilly USA, LLC1$31
Ferring Pharmaceuticals Inc.1$25
Janssen Biotech, Inc.1$24

Products named: REZDIFFRA, XELJANZ, RINVOQ, ENTYVIO, DUPIXENT, Sucraid, ZEPBOUND, REBYOTA.

Industry payments across MA — which companies pay providers there.